Fall 2013

Week 13 & 14

Week 11 & 12

Missing analysis. more data? -UM

Positive Control Ligands
MZM
EZL
GRE
a09
HQE
1QV
TOR
BEW
AZM
IE2


Negative Control Ligands
Aspirin
34375942
6425551
84844675
8698501
11535796
Figure 27: Table of positive and negative control ligands used for virtual screening of MTcanA protein.



NNNNNNNNNNNNNNNNNNNNNNNNNNNTNNGNNNNTTGNCNGNNNCNTNNTCNNCNTCTTTNTTCTGGCGNNNATCNGGN
NNNNNNNNNNNGNNNNTNNAATCNANGNCCGTTANNNNNACNTNNNNNNNNNAAAGGNNATCTCTCTTTNTNGCNCNTNN
CNCGTGAAATCNTNCNGNNNCNCNANNNCNAAGNGGNNNNNNNNNNNNNNNNNNNNGACTTNNNTNNNNATTCNNGANNA
ANCCCGTATNNNTCCNANCNGNTNNCCNGNNTCNNCNCCGTNNNTTCCACNTNNNNCGTTTTAGCTNNNNNNNNN
Figure 28: MTcanA_rev sequence for cloning attempt #1. Sequence results were abnormally shorter than gene length. Sequence also contains a large amount of unknown nucleotide bases. Query was

NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN
NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNCGNANNANNGNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNC
NNNNGNNNNNNNNANGATTTTNCNNNATTCNAANNNANCCTTTTTCTNNCAANAGNGGGCCNANNNNTTTTTTTNAANNN
CNNAATTNNCNCTTTCNTTNNNNNGCNNNNNTNAANCCTTGTAANANNANCGGTTTTNNNNNCACANTGCCCTTTTTTTT
NNNNNNNNNCCCNGCATTTTTGGGCNNAAAAGGGNCCCCTTTTTTTTTNNNNNCCCCCCCCCGAAAAGAAAAANTNGACC
CCCCCNCAANCANAAAAANNTTTGTGGTANTGGAGGGANCCCANNNNTTTTTTTTAACNGNGGCCTTNNAAANNNNGNTT
TNNNNNNNNNNNNNNNNGNCNNNNAAAAGCNNNN
Figure 29: MTcanA_for sequence for cloning attempt #1. Sequence results were abnormally shorter than gene length. Sequence also contains a large amount of unknown nucleotide bases.


When submitting a nucleotide BLAST on MTcanA for cloning attempt #1, a message of "No significant similarity" resulted.

NNNNNNNNNNNNNNGNNCTCNGTGGTGGTGGTGGTGGTGCTCGAGTGCGGCCGCAAGCTTGTCGACGGAGCTCGAATTCG
GATCCGTATCCACCTTTACTGTTACGGGGTAACCTCGTTCAGTTTACCGGTCGCAACGTCAAAGACGAAACCACGCAGAG
AGGTGTGTTTAGTAACGAACGGGTTCACTTCAATGCGGCGCAGGCTCTGACGTACATCTTCAACCGCGTCCGGGTAAGAT
TCCGGAGACCAGGTCGGACGGATACCGGTTTCATCCTGAATCGCGCGTTTGAAGTCGTCGTCGGTGAAGTGAGCATACCA
CAGTCGGTGTGGTGCAGCAGAATGATTTCACGGGTACCGAGCAGACGCTGAGAGATCGCCAGAGAACGGATAACGTCATC
GGTAACGGTCATGGATTGGAAGTACAGGTTCTCGGTACCCAGATCTACNCCAGAAGAATGATGATGATGATGGTGCATNT
NNNTTTCTCCTTCTTAAAGTTNAANNNAATTNNTTCTAGAGGGGAATTGNNNTACGATNNNNGNNNNCNTGTANANNGNG
ANAANNNANNNNNATAATCANNANGANNGAGNNNNNNAANTN
Figure 30: MTcanA_rev sequence for cloning attempt #2. Sequence results looked better than the first attempt, however, the identity was only 93% and the query was 61%.

NNNNNNNNNNNNNACTTTAGNNGAGANATACATATGCACCATCATCATCATCATTCTTCTGGTGTAGATCTGGGTACCGA
GAACCTGTACTTCCAATCCATGACCGTTACCGATGACGTTATCCGTTCTCTGGCGATCTCTCAGCGTCTGCTCGGTACCC
GTGAAATCATTCTGCTGCACCACACCGACTGTGGTATGCTCACTTCACCGACGACGACTTCAAACGCGCGATTCAGGATG
AAACCGGTATCCGTCCGACCTGGTCTCCGGAATCTTACCCGGACGCGGTTGAAGATGTACGTCAGAGCCTGCGCCGCATT
GAAGTGAACCCGTTCGTTACTAAACACACCTCTCTGCGTGGTTTCGTCTTTGACGTTGCGACCGGTAAACTGAACGAGGT
TACCCCGTAACAGTAAAGGTGGATACGGATCCGAATTCGAGCTCCGTCGACAAGCTTGCGGCCGCACTCGAGCACCACCA
CCACCACCACTGAGATCCGGCTGCTAACAAAGCCCGAAAGGAAGCTGAGTTGGCTGCTGCCACCGCTGAGCAATAACTAG
CATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTGCTGAAAGGAGGAACTATATCCGGATTGGCGAATGGG
ACGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGCANCGTGACCGCTACACTTGNCAGCGCCCTA
GCGCCCGCTCNTTTCGCTTTCTNCCCNTCCTTTTCACGCCACGTNCGCCGGCTTTCCCCGTTAAGNTCTAAATCNGGGGN
NTCCCNTTAGGGNTCNNANNNNNGCTANNNNNGNACCNCNACNNNAAAANNNNTNANNGNNATNNGNTNTTNNNANTNNN
NCNTN
Figure 31: MTcanA_for sequence for cloning attempt #2. Sequence results looked better than the first attempt, however, the identity was only 93% and the query was 61%.

NJF377NJF377.JPG
Figure 32: MTcanA_for nucleotide BLAST results from cloning attempt #2 showing 93% identity.




Week 9 & 10


Oligo mix was remade from original primers. Tail primers, MTcanA_for and MTcanA_rev were also remade to rule out any possibilities for primer dimers. This time, secondary PCR showed much less primer dimers, though they still appeared. PCR squared will be performed to see if gel extraction will be possible.

NJF377_secondaryPCR_102513.JPG
Figure 24: MTcanA secondary PCR run at 58°C after remaking oligo mix and tail primers. First lane is 1kb ladder, second lane is primary PCR, third lane is secondary PCR. Some primer dimers are still visible, but are much more faint than before.


NJF377_secondary&squaredPCR_102913.JPG
Figure 25: PCR of MTcanA run at 58.8°C. First lane is 1kb ladder, second lane is secondary PCR of MTcanA gene, and third lane is PCR squared of MTcanA gene.


NJF_KHV_cutPNIC_110113.JPG
Figure 26: Gel of cut pNIC-bsa4. First lane is 1 kb ladder. Second and third lane are Katherine's. Fourth lane is 30.9 ng/uL cut pNIC-bsa4, and fourth lane is 87.8 ng/uL cut pNIC-bsa4.


Virtual work has been started on the 1YLK protein with positive and negative control ligands. So far, only the control library of compounds has been concatenated.

Week 7 & 8


Secondary PCR was performed on a temperature gradient from 58°C to 68°C. Primer dimers still formed within all samples.


NJF377_PCR2tempgradient_101313.png
Figure 22: MTcanA secondary PCR temperature gradient. Lane 1 is 1kb ladder, lane 2 is 68°C, lane 3 is 67.3°C, lane 4 is 66.1°C, lane 5 is 64.3°C, lane 6 is 62°C, lane 7 is 60.3°C, lane 8 is 59°C, and lane 9 is 58°C. All samples show primer dimers as well as the MTcanA gene.


Secondary PCR was then done using 0.5uL of forward and reverse primers instead of 1.0uL. A lower annealing temperature of 56°C and the original annealing temperature of 58.8°C were used.

NJF377_2PCR_0.5uLprimers_101313.png
Figure 23: MTcanA secondary PCR. First lane is 1kb ladder. Second lane is 58.8°C sample. Third lane is 56°C sample. Both samples were made with 0.5uL of forward and reverse primers instead of the original 1.0uL. The second lane sample shows primer dimers. The third lane sample did not work, showing that 56°C is too low of an annealing temperature.


Week 5 & 6

VDS_NJF_GE_092013.jpg
Figure 20: Gel run for gel extraction on PCR sqaured for MTcanA. First lane is 1kb ladder. All other lanes are PCR squared samples. PCR squared samples show bands of contamination. These samples were used for gel extraction.

Gel extraction and PCR cleanup were performed using the PCR squared gels. Insufficient amount of MTcanA was retrieved due to contamination of the sample.

NJF377_2pcr_100713_good.JPG
Figure 21: Secondary PCR of MTcanA with extended annealing temperature. First lane is 1kb ladder. Second lane is secondary PCR. No contamination is shown. Extra bands represent primer dimers as a result of incorrect annealing temperature.


Secondary PCR was repeated using extended annealing times. There was no contamination, however, the gel indicates that primer dimers have been created the secondary PCR sample. To solve this issue, a temperature gradient will be used for the annealing temperatures.

Week 3 & 4

pNICbsa4 from week 2 was nanodropped. The concentration was found to be 69.8 ng/uL. This sample of pNICbsa4 was submitted for DNA sequencing with the forward and reverse primers pLIC_for and pLIC_rev.

NJF377_pNICbsa4_091113(1).jpg
Figure 17: pNIC-bsa4 nanodrop (run 1) showing a concentration of 69.2 ng/uL. This was averaged with the concentration found in run 2 when submitting to DNA sequencing for an average concentration of 69.2 ng/uL.

NJF377_pNICbsa4_091113(2).jpg
Figure 18: pNIC-bsa4 nanodrop (run 2) showing a concentration of 70.4 ng/uL. This was averaged with the concentration found in run 1 when submitting to DNA sequencing for an averaged concentration of 69.8 ng/uL.


Primary and secondary PCR on MTcanA were completed and run on a gel. Secondary PCR shows two bands. Band at 516bp is the needed MTcanA. Lower band is a contaminant. PCR squared will be done to amplify MTcanA, however, gel extraction may need to be done if contaminant still remains after PCR squared.
NJF377_MTcanA_2PCR_091313.JPG
Figure 19: Secondary PCR of MTcanA with new tail primers MTcanA_for and MTcanA_rev. First lane is 100bp ladder, second lane is 1kb ladder, third lane is primary PCR and fourth lane is seconday PCR showing two bands. Band at 516bp is MTcanA. Other band is contaminant.


Week 1 & 2**

New tail primers were ordered (MTcanA_for and MTcanA_rev) for target. These primers were each diluted from the original amount of 33.2 nMoles (MTcanA_for) and 33.4 nMoles (MTcanA_rev) to a stock dilution of 100uM. From this stock dilution, working dilutions of 20uM were made of each. An oligo mix for MTcanA was also made.

pNICbsa4 was grown up overnight and midiprepped.






Summer 2013


Week 8
NJF377_3rdattempt_secondaryPCR_canA (1).JPG
Figure 14: Second attempt at secondary PCR of canA. First lane is 1kb ladder, second lane is seconday PCR. Procedure was not changed from the first attempt.


NJF_secondarypcr_2ndattempt.jpg
Figure 15: Third attempt at secondary PCR of canA. First lane is 1kb ladder, second lane is seconday PCR. Annealing temperature was changed to 58.8 degrees Celsius.


NJF377_4thattempt_secondaryPCR_canA.JPG
Figure 16: Fourth attempt at secondary PCR of canA. First lane is 1kb ladder, second lane is primary PCR, third lane is seconday PCR. Primary PCR was redone to ensure a good base for secondary PCR.


New tail primers were ordered and these will be used to re-run secondary PCR.

Week 7
NJF 1st secondary PCR (unsuccessful).JPG
Figure 13: Primary and Secondary PCR of canA. First lane is 1kb ladder, second lane is primary PCR, and third lane is seconday PCR. Secondary PCR was unsuccessful.


Updated target page: β-carbonic anhydrases

Week 6

NJF RE digest 07-08-13.JPG
Fig 12: Restriction Enzyme digest gel; Lane 1: 1 kb ladder; Lane 2: uncut plasmid; Lane 3: EcoRI; Lane 4: PvuII; Lane 5: EcoRI and PvuII.


Week 5
PCR on pGBR22 was successful.

NJF377_successatgelforPGBR22.JPG
Figure 11: Fourth attempt (success!) at agarose gel of pGBR22 plasmid. Lane 1: 1kb ladder; Lane 2: sample A; Lane 3: sample B; Lane 4: sample C; Lane 5: sample D (control lane).


Target Assigned: Beta-carbonic anhydrase (canA) (Mycobacterium tuberculosis)
Primers ordered: mtcanARev1284_FOR, mtcanARev1284_REV

Week 4
njf377_pcr_pgbr22_.jpg
Figure 10: Third attempt at agarose gel of pGBR22 plasmid. Right lanes are Nicolet's and left lanes are Katherine's. Lane 1: ladder; Lane 2: sample A; Lane 3: sample B; Lane 4: sample C; Lane 5: sample D. No visible bands.


Week 3
PCR was done using pGBR22 from Week 2 and run on a gel for better results. This time it showed contamination.

KHV pgbr22.JPG
Figure 9: First attempt at agarose gel of pGBR22 plasmid. Left lanes are Nicolet's and right lanes are Katherine's. Lane 1: ladder; Lane 2: sample A; Lane 3: sample B; Lane 4: sample C; Lane 5: sample D. Left lanes show contamination. Right lanes do not show results.


BL21(DE3) cells were used to transform an overnight culture of pNIC-Bsa4 in 100 ml LB. The next morning, the culture was transferred to a 500mL LB flask. 20 ml of the culture was transferred to a larger culture, stored in the shaking incubator, and checked every 30 minutes until an OD 600 of 0.625 was reached. This culture was then stored in the shaking incubator for 4 hours. The pNIC-Bsa4 culture was spun down and re-suspended in buffer to be stored at -80 degrees Celsius.

Week 2
mth793_Nanodrop1_purple[1].jpg
Fig 6: Absorbance reading of sample 1 of pGBR22 plasmid.


mth793_Nanodrop2_purple[1].jpg
Fig 7: Absorbance reading of sample 2 of pGBR22 plasmid.

NJF377_gel.JPG
Figure 8: First attempt at agarose gel of pGBR22 plasmid. Left lanes are Nicolet's and right lanes are Brenden's. Lane 1: ladder; Lane 2: sample A; Lane 3: sample B; Lane 4: sample C; Lane 5: sample D. No visible bands.


Week 1
Bacteria_njf377 (2).JPG
Figure 1: E. coli cells transformed with 1 ng pGBR22 plasmid grown on LB+Amp Agar plates.

Bacteria_njf377 (1).JPG
Figure 2: E. coli cells transformed with 5 ng pGBR22 plasmid grown on LB+Amp Agar plates.

Bacteria_njf377 (3).JPG
Figure 3: E. coli cells transformed with 25 ng pGBR22 plasmid grown on LB+Amp Agar plates.


Transformation Efficiency:
Plate A, Fig. 1 (1 ng pGBR22): 3 Colonies
Plate B, Fig. 2 (5 ng pGBR22): 252 Colonies
Plate C, Fig. 3 (25 ng pGBR22): 1,920 Colonies

NNNNNNNNNNNNNNCGANTGGGCCCGACGTCGCATGCTCCCGGCCGCCATGGCCGCGGGATTTTAGTGATGGTGATGGTG
ATGACCGAGCAAAGAGTGGCGTGCAATGGATATTTCACACTGCTCAACAAATGTGTAATCCTTGTTGTGACTGGTTACAT
CCAGTTTGCGGTCAACATAGTGATACCCTGGCATCCTCACAGGCTTCTTTGCCTTGTAAGTAGATTTGAATTCACACAAA
TAGTAACCACCTCCTTCCAACTTCAGAGCCATAAAGTTGTTTCCTATCAGCATTCCATCTCGTGCAAAGAGACGCTCAGT
GTTGGGTTCCCAGCCCTGTGTCTTCTTCTGCATAACAGGTCCATTGGGAGGAAAGTTCACACCAGAGATTTTGACATTGT
AGATGAAACAGTTGCCTTGGATGCTGGAATCATTGCTGACAGTACACACTGCACCATCTTCAAAGTTCATGATCCTCTCC
CATGTATATCCCTCAGGGAATGACTGCTTTACATAATCAGGGATGTCTTCAGGGTACTTGGTGAATGGTATGCTTCCGTA
TTGAGACAGTGGTGATAAAATATCCCAAGCAAATGGCAGAGGTCCACCCTTGGTGACAGTGAGCTTTACCGTCTGCTCCC
CCTCGTAAGGCTTTCCTTTTCCATCGCCTTCGACCTCAAAGTAGTGTCCATTGACCGTGCCTGACATATAAACCTTGTAG
GTCATTTGTTTAGCGATCACACTCATGATATTTCTCCTTCAATCAATCAAAATCACTAGTGCGGCCGCCTGCAGGTCGAC
CATATGGGAGAGCTCCCAACGCGTTGGATGCATAGCTTGAGTATTCTATAGTGTCACCTAAATAGCTTGGCGTAATCATG
GTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAG
CCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTNNNAAANNTGTCNN
GNCAGCTGCATTAATGATCGGCNANNNNCGGGGNNANGNNNNTNGCGTNTGGGNNCTCTTCNNNTCCTCNNTCANNGACT
CNNNNNNNTCNNNCNNNNNNNNNNNNNNNNNGNNTCANNNNNNNNNANGNNNGNNNNNNNNNNNNNNNNNNNNNNNNNNN
ANNNNNNNGNAANANNNNNNNNNNNNNNNNNNNNAANNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNTNNN
NNN
Figure 4: DNA sequencing-pGBR22.